Old Web
English
Sign In
Acemap
>
authorDetail
>
Cheryl A. Gretzula
Cheryl A. Gretzula
Merck & Co.
Genetics
Risk factor
Disease
Biology
Bioinformatics
2
Papers
26
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (2)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
A novel glucosylceramide synthase inhibitor attenuates alpha synuclein pathology and lysosomal dysfunction in preclinical models of synucleinopathy.
2021
Neurobiology of Disease
Mali Cosden
Sarah Jinn
Lihang Yao
Cheryl A. Gretzula
Monika Kandebo
Dawn Toolan
Nathan G. Hatcher
Lei Ma
Wei Lemaire
Gregory C. Adam
Christine Burlein
Christina Minnick
Rose B. Flick
Marla L Watt
James Mulhearn
Mark E. Fraley
Robert E. Drolet
Jacob Marcus
Sean M. Smith
Show All
Source
Cite
Save
Citations (0)
Functionalization of the TMEM175 p.M393T Variant as a risk factor for Parkinson Disease
2019
Human Molecular Genetics
Sarah Jinn
Cornelis Blauwendraat
Dawn M. Toolan
Cheryl A. Gretzula
Robert E. Drolet
Sean M. Smith
Mike A. Nalls
Jacob Marcus
Andrew B. Singleton
David J. Stone
Show All
Source
Cite
Save
Citations (26)
1